Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 105

Sort by

Sort Order Select

Journal Articles

Renal Response of Selinexor, Pomalidomide, Bortezomib and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients with Renal Impairment: Preliminary Analysis from a Phase 2, Prospective, Multicenter Study

Blood (2024) 144 (Supplement 1): 1978.

https://doi.org/10.1182/blood-2024-201978

Published: 2024

Journal Articles

Polatuzumab Vedotin, Rituximab and Lenalidomide (Pola-R 2 ) As First-Line Therapy for Unfit and Frail Elderly Diffuse Large B-Cell Lymphoma Patients: Preliminary Result of a Prospective, Phase II, Multi-Center Study

Wei Wang, Xu Zhang, Qihui Li, Hua Yin, Xiubin Xiao, Jian Li, Wenrong Huang, Hongmei Jing, Yan Zhang

Blood (2024) 144 (Supplement 1): 1728.

https://doi.org/10.1182/blood-2024-198294

Published: 2024

Journal Articles

PLK1 Acts in Homologous Recombinatorial Repair and in Mitosis As Synthetically Lethal with the Fanconi Anemia/BRCA Pathway

Gary Kupfer, Paymon Doroodian, Jian Li, Erica Golemis, Paul Young, Emily Stahl, Arvin Nagarajan, Patrick Sung, Barbara Burtness

Blood (2024) 144 (Supplement 1): 2705.

https://doi.org/10.1182/blood-2024-200980

Published: 2024

Journal Articles

Timing of Response with Gilteritinib Monotherapy in Relapsed or Refractory FLT3 -Mutated Acute Myeloid Leukemia

Alexander E. Perl, Mark J. Levis, Andrew Wei, Hee-je Kim, June-won Cheong, Yu Zhang, Jian Li, Hisayuki Yokoyama, Naoko Hosono, Nahla Hasabou, Dina Elsouda, Jamie Jung-Hee An, Jianxiang Wang

Blood (2024) 144 (Supplement 1): 2889.

https://doi.org/10.1182/blood-2024-204831

Published: 2024

Journal Articles

Modified Staging System for Patients with Waldenstrom's Macroglobulinemia in a Chinese Cohort

Jia Chen, Jian Li, Daobin Zhou, Xinxin Cao

Blood (2024) 144 (Supplement 1): 6892.

https://doi.org/10.1182/blood-2024-210305

Published: 2024

Journal Articles

A Novel Conditioning Regimen Combining Selinexor with Melphalan Could Improve Survival of Patients with Multiple Myeloma

Liangliang Ma, Jingping Zhang, Xiaoqing Chen, Shanglun Yang, Youmei Fei, QIan Hu, Jian Li, Caigang Xu, Ting Niu, Yongqian Jia

Blood (2024) 144 (Supplement 1): 7066.

https://doi.org/10.1182/blood-2024-206877

Published: 2024

Journal Articles

Quality of Life after Idiopathic Multicentric Castleman Disease in China: A Cross-Sectional, Multi-Center Survey of Patient Reported Outcome and Caregiver Reported Outcome

Jia Chen, Miaoyan Zhang, Yuhan Gao, Lu Zhang, Jian Li

Blood (2024) 144 (Supplement 1): 7852.

https://doi.org/10.1182/blood-2024-210512

Published: 2024

Journal Articles

The Clinical Characteristics and Prognostic Analysis of Prolonged Cytopenia after CAR-T Cell Therapy

Huiying Zhu, Danqing Zhao, Zhe Zhuang, Chao Chen, Wei Zhang, Daobin Zhou, Jian Li, Yan Zhang

Blood (2024) 144 (Supplement 1): 7148.

https://doi.org/10.1182/blood-2024-207024

Published: 2024

Journal Articles

Potential Opportunity for Drug Discontinuation in Idiopathic Multicentric Castleman Disease: Evaluating the Efficacy of TCP Protocol

Yue Dang, Yuhan Gao, Siyuan Li, Lu Zhang, Jian Li

Blood (2024) 144 (Supplement 1): 6310.

https://doi.org/10.1182/blood-2024-206712

Published: 2024

Journal Articles

Venetoclax Plus Dexamethasone As First-Line Treatment for t(11; 14) Light-Chain Amyloidosis: Preliminary Result of a Phase II Prospective, Multicenter, Single-Arm Study

Kaini Shen, Ai Guan, Yu Wu, Chunyan Sun, Liye Zhong, Jun Luo, Jian Li

Blood (2024) 144 (Supplement 1): 893.

https://doi.org/10.1182/blood-2024-204346

Published: 2024

Journal Articles

Multicenter Real-World Use of Polatuzumab Vedotin in Diffuse Large B-Cell Lymphoma(DLBCL) of Frontline and Relapse/Refractory Settings in China

Zhangyuting He, Huiying Zhu, Chong Wei, Danqing Zhao, Wei Wang, Jian Li, Wei Zhang, Daobin Zhou, Yan Zhang

Blood (2024) 144 (Supplement 1): 6504.

https://doi.org/10.1182/blood-2024-203008

Published: 2024

Journal Articles

Chemo-Free Salvage Treatment Is Better Than Traditional Chemotherapy in Relapsed/Refractory Subcutaneous Panniculitis-like T-Cell Lymphoma

Chao Chen, Jingjing Yin, Minghui Duan, Chong Wei, Congwei Jia, Wei Zhang, Jian Li, Daobin Zhou, Yan Zhang

Blood (2024) 144 (Supplement 1): 6400.

https://doi.org/10.1182/blood-2024-203578

Published: 2024

Journal Articles

CHOP Is Insufficient for Newly-Diagnosed Subcutaneous Panniculitis-like T-Cell Lymphoma Patients: A Retrospective Study of 32 Patients in China

Chao Chen, Jingjing Yin, Wei Wang, Danqing Zhao, Chong Wei, Cong-Wei Jia, Wei Zhang, Jian Li, Daobin Zhou, Yan Zhang

Blood (2024) 144 (Supplement 1): 6395.

https://doi.org/10.1182/blood-2024-202966

Published: 2024

Journal Articles

Tafro Syndrome without Pathological Evidence Consistent with Castleman Disease: A Subtype of Tafro or a Distinct Disease Entity?

Siyuan Li, Yuhan Gao, Yue Dang, Lu Zhang, Jian Li

Blood (2024) 144 (Supplement 1): 6298.

https://doi.org/10.1182/blood-2024-204501

Published: 2024

Journal Articles

Real-World Data of Siltuximab for Chinese Patients with Imcd: Combination with BCD Regimen Benefits Severe Cases

Siyuan Li, Yuhan Gao, Yue Dang, Long Chang, Kaini Shen, Huacong Cai, Danqing Zhao, Chong Wei, Jun Feng, Lu Zhang, Jian Li

Blood (2024) 144 (Supplement 1): 6292.

https://doi.org/10.1182/blood-2024-203586

Published: 2024

Journal Articles

Efficacy and Safety of Orelabrutinib in Relapsed/Refractory Idiopathic Multicentric Castleman Disease: A Single-Center, Retrospective Study

Yuhan Gao, Siyuan Li, Yue Dang, Minghui Duan, Jian Li, Lu Zhang

Blood (2024) 144 (Supplement 1): 1656.

https://doi.org/10.1182/blood-2024-204570

Published: 2024

Journal Articles

Asymptomatic Multicentric Castleman Disease: A Potential Early Stage of Idiopathic Mcd

Blood (2024) 144 (Supplement 1): 4417.

https://doi.org/10.1182/blood-2024-204513

Published: 2024

Journal Articles

The De Novo Sequencing of Full-Length Amyloidogenic Light Chain By Peripheral Blood Mass Spectrometry

Ai Guan, Kaini Shen, Wei Su, Bing Wang, Bin Ma, Jian Li

Blood (2024) 144 (Supplement 1): 4988.

https://doi.org/10.1182/blood-2024-204407

Published: 2024

Journal Articles

Decitabine Plus All- Trans Retinoic Acid Versus Decitabine Monotherapy for Myelodysplastic Syndromes with Excess Blasts: A Multicentre, Randomized Controlled Trial

Blood (2024) 144 (Supplement 1): 663.

https://doi.org/10.1182/blood-2024-200433

Published: 2024

Journal Articles

Adult Langerhans Cell Histiocytosis with Liver Involvement

Long Chang, Lin He, Huacong Cai, Minghui Duan, Jian Li, Daobin Zhou, Gaurav Goyal, Xinxin Cao

Blood (2023) 142 (Supplement 1): 3197.

https://doi.org/10.1182/blood-2023-184790

Published: 2023

NARROW

Renal Response of Selinexor, Pomalidomide, Bortezomib and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients with Renal Impairment: Preliminary Analysis from a Phase 2, Prospective, Multicenter Study

Polatuzumab Vedotin, Rituximab and Lenalidomide (Pola-R 2 ) As First-Line Therapy for Unfit and Frail Elderly Diffuse Large B-Cell Lymphoma Patients: Preliminary Result of a Prospective, Phase II, Multi-Center Study

PLK1 Acts in Homologous Recombinatorial Repair and in Mitosis As Synthetically Lethal with the Fanconi Anemia/BRCA Pathway

Timing of Response with Gilteritinib Monotherapy in Relapsed or Refractory FLT3 -Mutated Acute Myeloid Leukemia

Modified Staging System for Patients with Waldenstrom's Macroglobulinemia in a Chinese Cohort

A Novel Conditioning Regimen Combining Selinexor with Melphalan Could Improve Survival of Patients with Multiple Myeloma

Quality of Life after Idiopathic Multicentric Castleman Disease in China: A Cross-Sectional, Multi-Center Survey of Patient Reported Outcome and Caregiver Reported Outcome

The Clinical Characteristics and Prognostic Analysis of Prolonged Cytopenia after CAR-T Cell Therapy

Potential Opportunity for Drug Discontinuation in Idiopathic Multicentric Castleman Disease: Evaluating the Efficacy of TCP Protocol

Venetoclax Plus Dexamethasone As First-Line Treatment for t(11; 14) Light-Chain Amyloidosis: Preliminary Result of a Phase II Prospective, Multicenter, Single-Arm Study

Multicenter Real-World Use of Polatuzumab Vedotin in Diffuse Large B-Cell Lymphoma(DLBCL) of Frontline and Relapse/Refractory Settings in China

Chemo-Free Salvage Treatment Is Better Than Traditional Chemotherapy in Relapsed/Refractory Subcutaneous Panniculitis-like T-Cell Lymphoma

CHOP Is Insufficient for Newly-Diagnosed Subcutaneous Panniculitis-like T-Cell Lymphoma Patients: A Retrospective Study of 32 Patients in China

Tafro Syndrome without Pathological Evidence Consistent with Castleman Disease: A Subtype of Tafro or a Distinct Disease Entity?

Real-World Data of Siltuximab for Chinese Patients with Imcd: Combination with BCD Regimen Benefits Severe Cases

Efficacy and Safety of Orelabrutinib in Relapsed/Refractory Idiopathic Multicentric Castleman Disease: A Single-Center, Retrospective Study

Asymptomatic Multicentric Castleman Disease: A Potential Early Stage of Idiopathic Mcd

The De Novo Sequencing of Full-Length Amyloidogenic Light Chain By Peripheral Blood Mass Spectrometry

Decitabine Plus All- Trans Retinoic Acid Versus Decitabine Monotherapy for Myelodysplastic Syndromes with Excess Blasts: A Multicentre, Randomized Controlled Trial

Adult Langerhans Cell Histiocytosis with Liver Involvement

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only